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Abstract
Purpose To evaluate the feasibility of ex vivo 7T MRI to assess surgical margins (SMs) and pseudocapsule (PC) features after
partial nephrectomy (PN).
Materials and methods In this prospective, IRB-approved study, seven patients undergoing a PN for nine tumours between
November 2014 and July 2015 were included for analysis after obtaining informed consent. MRI of the specimen was acquired
using a 7T small bore scanner. The imaging protocol consisted of anatomical T1-, T2- and diffusion-weighted imaging. After
formalin fixation, specimens were cut for pathology work-up in the same orientation as the MR images were obtained. The entire
specimen was processed into H&E slides that were digitally scanned, annotated and correlated with radiological findings for
negative SMs, PC presence, PC continuity and extra-PC-extension (EPCE). Sensitivity and specificity of MRI for assessment of
these endpoints were calculated.
Results The sensitivity and specificity for assessment of the SM were 100% and 75%, respectively. Two false-
positive outcomes were reported, both in case of EPCE and a SM ≤0.5 mm. For the presence of a PC, sensitivity
and specificity were 100% and 33%, respectively. Two false-positive scans with anatomical structures mimicking the
presence of a PC occurred. If a PC was present, continuity and EPCE were assessed with a sensitivity and
specificity of 75% and 100% and 67% and 100%, respectively.
Conclusion Ex vivo 7TMRI is a feasible tool for perioperative evaluation of SMs, and if present, PC features after PN. This may
facilitate maximal sparing of renal parenchyma without compromising oncological outcomes.
Key Points
• Ex vivo MRI may contribute to improvement of negative surgical margins during partial nephrectomy.
•Due to the assessment of surgical margins within a limited time span from obtaining the partial nephrectomy specimen, surgery
for more complex tumours is possible with maximum sparing of healthy renal parenchyma without compromising oncological
outcomes.
• The intra operative assessment of pseudocapsule continuity along the resection margin enables maximal sparing of healthy
renal parenchyma without delayed diagnosis of incomplete resection.
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Introduction
The standard of care for renal masses not exceeding 7 cm in
diameter is partial nephrectomy (PN) whenever feasible [1]. A
negative surgical margin (SM) is one of the key trifecta out-
comes during PN, next to minimal renal function decrease and
the absence of complications [2]. This challenges the urologist
to minimise SMs in order to maximally preserve healthy renal
parenchyma without compromising oncological outcomes [3].
With the narrowing of SMs the need for intraoperative SM
assessment grows. This includes an accurate assessment of the
tumour pseudocapsule (PC) present in the majority of malig-
nant renal tumours [4], mainly because enucleation along the
plane between the tumour PC and the renal parenchyma is an
established approach to preserve healthy parenchyma [3].
Despite its relevance, intra-operative SM and PC assessment
remains a challenging task. In particular, because frozen sec-
tion analysis is considered not to be contributory due to sev-
eral studies evaluating 380 cases that failed to show any true
positive results [5–7]. Therefore, to assess SMs, the use of ex
vivo specimen imaging might be of added value. We hypoth-
esized that ex vivo MRI of renal tumour specimens is a feasi-
ble tool to assess SMs and PC features following PN.
The objective of this study was to evaluate the feasibility of
ex vivo 7TMRI to assess SMs and PC features after PN and to
correlate our findings with whole mount section histopathol-
ogy as the gold standard.
Materials and methods
Recruitment
The Institutional Review Board approved this study. All pa-
tients gave written informed consent. Data were prospectively
collected between November 2014 and July 2015. Inclusion
criteria were a clinically suspicious tumour for RCC, sched-
uled PN and obtained written informed consent. No exclusion
criteria were imposed. Patients were recruited and consecu-
tively selected at the urology outpatient clinic. In total, ten
specimens containing 11 tumours from nine patients were
included. One specimen contained an incidentally detected
second tumour that was included for analysis. One specimen
consisted of a benign cyst and in one specimen perioperative
disintegration of the resection margin occurred, both were
excluded from analysis (Table 1).
Surgery
PN was performed by open or robotic approach. Before resec-
tion, warm ischaemia time was applied by clamping the renal
artery. Tumour resection was done with a minimal healthy
tissue margin technique. If feasible, enucleation along the tu-
mour PC was performed without resecting healthy parenchy-
ma. The resection technique was macroscopically scored by
one observer (TO) as pure enucleation, hybrid enucleation,
pure enucleoresection or hybrid enucleoresection or resection
according to the surface–intermediate–base margin score [8].
Specimen MR imaging
Following resection, the specimen was transported to the MR
suite. After inking the parenchymal SM and renal capsule site,
the specimen was fixated with wooden pins on a paraffin
block within a customised Perspex holder containing rows
of Perspex pins 3 mm apart from each other (Fig. 1). This
holder and pins were designed to align imaging orientation
with pathology slicing. The complete setup was positioned
in a glass container. The specimen was immersed in
perfluropolyether oil (Galden, Solvay Solexis) to avoid sus-
ceptibility artefacts. MR imaging was acquired using a 7T
horizontal wide bore (200 mm) ClinScan animal scanner
interfaced to a clinical Siemens Syngo VB15 console
(Bruker BioSpin). MR images were recorded using an inte-
grated circular polarized transmit/receive 1H volume coil with
a free inner diameter of 154 mm. To match the MR and his-
topathology slides, MR sequences were aligned with water-
filled tubes in the Perspex holder. The imaging protocol
contained anatomical T1-weighted 3D gradient echo, T2-
weighted turbo spin-echo (TSE) sequences and diffusion-
weighted imaging (DWI) with b-values of 0–100–500–1,000
s/mm2 (see Table 2 for imaging parameters). Apparent diffu-
sion coefficient (ADC) maps were calculated using the stan-
dard ADC post-processing available on the console. The num-
ber of slices was chosen to entirely cover the specimen. The
total work-up time, measured from the time of the specimen
removal until availability of the images, was recorded.
MR imaging report
MR images were reviewed by a radiologist (JF) blinded for
the pathology outcome with 15 years of experience in the field
of MR imaging. Tumour size, smallest SM (defined as
smallest distance from the tumour border towards parenchy-
mal SM), SM negativity, presence or absence of a PC, and if
present, continuity of the PC and extra PC extension (EPCE)
were evaluated (Table 1).
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Image quality assessment
To establish which sequence was most suitable for evaluation,
the quality of the MR images was assessed by the reviewing
radiologist (JF), who evaluated the specimen characteristics.
Visual quality assessment was done by scoring visibility of
SM and PC features using a 5-point scale for all used se-
quences. Score 1 reflected excellent visualisation; score 5
reflected the images as being non-diagnostic.
Pathology workflow
After theMR imaging the specimenmaintained its position on
the board. After at least 24 h of fixation in formalin it was cut
in the same direction the MR images were obtained. To enable
proper correlation between theMR images and histopatholog-
ical slides, the landmarks on the board were used. The speci-
men slides obtained were paraffin embedded after which 4 μm
haematoxylin and eosin slides were prepared. All tumour-
containing slides were digitally scanned (3DHistech
Panoramic250, SYSMEX Belgium N.V., and Olympus
Dotslide, Olympus Nederland B.V.). While being blinded for
the MR imaging results, histopathological annotation on all
scanned slides was done by two residents in pathology (WR/
EB) under supervision of a dedicated uropathologist with 25
years of experience (CH) using commercially available soft-
ware (Aperio ImageScope v11.2.0.780, Aperio Technologies,
Inc. and OlyVIA, Olympus).
Pathology report
All features as reported by the radiologist were also histo-
logically evaluated. In addition, histological RCC subtype
according to the 2016 World Health Organization (WHO)
classification and International Society of Urological
Pathology (ISUP) nuclear grading were reported [9, 10].
On histopathology a PC was defined as a band of fibrous
connective tissue located at the interface of the tumour and
adjacent renal parenchyma [11] (Table 1). EPCE was de-
fined as complete penetration of the tumour through the
PC. The following conditions were not considered EPCE:
intact PC with tumour invasion, incomplete PC but no
Fig. 1 (a) Specimen I containing a 20-mm large oncocytoma, fixated on
a block of paraffin inside a customised Perspex holder with a Perspex row
of pins on both sides 3 mm apart, used for pathology slicing after fixation
in formalin. The holder also contains seven (two posterior left) water-
filled tubes (blue pins) to facilitate matching between MR imaging and
histopathology slides. The total setup is positioned in a glass container.
(b) After MR examination the oil in the glass container was disposed of
and the specimen was fixated at least 24 h in formalin. Subsequently, the
specimenwas cut in 3- to 5-mm thick whole mount sections from anterior
to posterior using the pins in the holder and totally included for pathology
work-up
Table 2 MR imaging parameters
Sequence Slides TR (ms) TE
(ms)
FA
(degrees)
ST
(mm)
Averages matrix FOV
(mm)
Pixel size
(mm)
Scan time
(min:s)
TSE 25-77 3,842–13,940 27 180 1 1 256*256 50*50 0.19*0.19 2:26–7:30
3D GRE 104-256 15 2.8 15 0.3 1 128–320*128–320 49–80*49–80 0.26*0.26 3:39–8:58
DWI 25-88 2,000 48 180 1 4 128*128 50*50 0.39*0.39 13:20–46:56
TSE turbo spin-echo,GRE gradient echo,DWI diffusion-weighted imaging, TR repetition time, TE echo time, FA flip angle, ST slice thickness,FOV field
of view
Variations in TR, number of slices and scan time were caused by variations in volume of the specimens. With changing specimen volumes, matrix and
FOV were adjusted for the third GRE sequence to maintain the voxel size
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tumour protrusion in the renal parenchyma, and PC with
protruding but no penetrating tumour [12]. A positive SM
was defined as presence of tumour cells in the inked sur-
face of the parenchymal resection border.
Statistical analysis
For descriptive analysis median (range) values were used.
Correlation between the radiological and pathological review
for tumour diameter and smallest SM was established using
Pearson’s r. A p-value <0.05 was considered statistically sig-
nificant. Sensitivity and specificity ofMRI were calculated for
assessment of PC and SM features.
Results
In total, nine tumours in eight specimens obtained from seven
patients were available for analysis. Five (71%) patients were
male, median age was 65 years (range 56–73). Robot-assisted
partial nephrectomy (RAPN) and open surgery were per-
formed in six and one patients, respectively. Median tumour
diameter on radiological and pathological review were 21 mm
(range 10–59) and 20 mm (5–70), respectively (Pearson’s r
0.978; p < 0.01). The total work-up time, measured from the
time of the specimen removal until availability of the relevant
images, was 80 min (range 42–186).
Visual quality assessment
Median scores for ability to assess SM and PC features were
excellent (score 1) using T2-weighted images. T1-weighted
images median scores were acceptable (score 3) with outliers
to non-diagnostic for assessment of both features. DW images
were least usable with median scores being acceptable (score
3) and poor (score 4) for assessment of SM and PC features,
respectively (Fig. 2 and Table 3).
Surgical margins
Median smallest SM was 2.7 mm (0.2–9.0) and 0.6 mm (0.3–
1.5) on radiological and pathological review (Pearson’s r
0.667; p = 0.147). One SM was on histological evaluation
found to be positive, which was identified as such on MR
imaging (Fig. 3). Two tumours showed a false-positive SM
on MR imaging. Presence of tumour cells in the SM was not
confirmed on histopathology in one case with a smallest SM
of 0.5 mm (Fig. 2). One specimen showed EPCE and in-
growth of the tumour in a blood vessel towards the parenchy-
mal resection border. Additional histopathological slides were
cut but the SM remained negative with the smallest margin
being 0.5 mm. The sensitivity and specificity for assessment
of negative SM with MR imaging were 100% (9/9) and 75%
(6/8), respectively.
Pseudocapsule
A PC was histologically confirmed in six out of nine cases.
Presence or absence of a PC was correctly identified on MRI
in seven out of nine cases (78%); two scans were false posi-
tive. In both cases an anatomical structure mimicking a tu-
mour PC was present. The first case concerned a papillary
RCC outlined by a thin epithelial layer of a cystic space,
thereby creating a delicate space that mimicked a PC (Fig.
4). In the second specimen, the renal capsule at the perirenal
site together with longitudinal cut blood vessels and com-
pressed parenchyma towards the surgical margin mimicked
a PC. Sensitivity and specificity for presence of a PC were
100% (6/6) and 33% (1/3), respectively.
Histopathologically determined PCs were discontinuous in
67% (4/6) and EPCE was present in 50% (3/6), respectively.
In one case both PC discontinuity and EPCE were not identi-
fied as such on MRI. Sensitivity and specificity for continuity
and EPCE were 75% (3/4) and 100% (2/2) and 67% (2/3) and
100% (3/3), respectively.
Discussion
We showed that MRI is a feasible and sensitive tool to assess
SMs following partial nephrectomy. Detection of PC presence
is challenging due to anatomical structures mimicking its ap-
pearance. If a PC is present, accurate evaluation of continuity
and EPCE is possible with a sensitivity of 75% and 67% and
specificity of 100% for both features. T2-weighted images
provide the best quality for evaluation.
Intraoperative evaluation of SMs plays an important role in
the emerging field of PN. Positive surgical margins are report-
ed in 0–7% after PN [13]. Enucleation can be used as a resec-
tion technique to facilitate maximal parenchymal sparing in
order to preserve renal function. However, it harbours the risk
of incomplete resection mostly due to PC absence or discon-
tinuity in several tumour subtypes [4, 11–13]. Also, PN per-
formed in an imperative indication, i.e. large tumours and
tumours with an unfavourable localisation, are prone to non-
radical resection, with 18 % positive SMs reported in the
literature [13, 14]. Especially in these cases, ex vivo imaging
to assess the SM can facilitate the surgeon in sparing healthy
renal parenchyma without compromising oncological
outcomes.
Previously, the feasibility for SM assessment using ex vivo
ultrasound (US) has been evaluated. In three studies
concerning 118 cases a specificity of 100% was found. The
high sensitivity in these studies (97–100%) should be consid-
ered with caution because each study only contained one
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positive SM [15–17]. The disadvantage of US is the user
dependency, making it prone to interobserver variability.
This makes these studies difficult to reproduce. Also, com-
pression of the specimen can cause tissue deformations on
imaging leading to misinterpretation of SMs. In case of ab-
sence of PC, US imaging can be challenging because tumour
echogenicity may be similar to that of parenchyma, while
MRI provides better soft tissue contrast. Moreover, US
imaging is hard to accurately correlate with final histopathol-
ogy because the imaging plane cannot be correlated with the
direction used for pathology slicing.
A more recent development is ex vivo fluorescence imag-
ing of the renal specimen after PN. The use of indocyanine
green in 16 patients showed a sensitivity and specificity of
100% for both for SM assessment. However, this cohort
contained no positive SMs [18]. Another recent study con-
firmed the feasibility of ex vivo fluorescence imaging using
IRDye800CW in six patients undergoing PN in whom one
positive SM was correctly identified [19]. An advantage of
fluorescence imaging is that imaging before, during and after
tumour resection can easily be combined [20].
The work-up time measured in this study was 80 min
(range 42–186). A large part of this time span involved the
time that was needed to optimise the scanning protocol and to
assure rigid methods to test the technical feasibility. If imple-
mented in clinical use, mounting of the specimen should take
about 2 min when done on site. This is in contrast to our study,
where mounting of the specimen was done at the pathology
laboratory to assure correct correlation with final histopathol-
ogy. Subsequent positioning in the MR scanner, adjustment
and reference imaging should take about 2–3 min.We suggest
using the T2-weighted sequence for which the scanning time
Fig. 2 (a) Specimen X containing a 24-mm large clear cell tumour and a
10-mm large incidentally detected papillary tumour. The T1-weighted
images show the clear cell (*) and papillary tumour (#), the surgical
margin (red line), and suspected positive surgical margin (yellow arrow.)
Image quality was scored as ‘3 – acceptable’. (b) According to
T2-weighted images. Image quality was scored as ‘1 – excellent’. (c)
According to calculated ADC map. Image quality was scored as ‘4 –
poor’. (d) Histopathological slide with enlargement shows demarcation
of the clear cell (green) and papillary (red) tumour. The enlargement does
not confirm tumour cells in the resection border
Table 3 Visual quality assessment of used sequences to assess surgical
margins (SMs) and pseudocapsule (PC) features
Median score Range
T1-weighted for SM Acceptable Acceptable – excellent
T1-weighted for PC Acceptable Acceptable
T2-weighted for SM Excellent Excellent
T2-weighted for PC Excellent Excellent
DWI for SM Acceptable Non-diagnostic – acceptable
DWI for PC Poor Poor
Possible outcomes: non-diagnostic, poor, acceptable, good, excellent
SM surgical margins, PC pseudocapsule, DWI diffusion-weighted
imaging
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is 3–7 min, depending on the specimen size. Reviewing the
MR images should also take about 2 min. The rest of the total
work-up time is dependent on logistical factors such as
location of the MRI and availability of a radiologist to review
theMR images. A total work-up should be feasible within 10–
15 min when optimal conditions are created.
Fig. 4 (a) Specimen VIII
containing a 70-mm papillary
tumour showing a false-positive
result for presence of a
pseudocapsule (red arrow) on the
T1-weighted scan; the specimen
is slightly compressed at the top
to fit in the setup. (b) The
annotated histopathological slide
shows the tumour borders (green
line). The black square is enlarged
in c. (c) The structure marked as
a pseudocapsule on MRI was
found to be a thin epithelial layer
surrounding the tumour
mimicking a pseudocapsule.
Markers are as follows: * tumour
tissue; # renal parenchyma, ^
adipose tissue; arrows mark the
epithelial layer
Fig. 3 (a) Preoperative CT scan
of specimen III showing a 50-mm
large clear cell RCC in the right
kidney. (b) The T2-weighted scan
of the specimen after resection
showed suspicion for a positive
(yellow arrow) surgical margin
(red line). (c) Histopathological
slide confirmed the 1.4-mm large
positive surgical margin. Black
box is enlarged in Fig. 3d. (d)
The 1.4-mm large positive
surgical margin in detail
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A limitation to this study is the small sample size. Reported
sensitivity should be interpreted cautiously because only one
case with a positive SM was included. The specificity of 75%
for SM assessment was hampered due to two cases showing a
false-positive result. Both cases had EPCE and a very small
resection margin (≤0.5 mm). However, the detection of a 1.4-
mm large positive SM indicates that larger positive SMs,
which are more important in terms of prognosis, can be de-
tected usingMR imaging [13]. Future studies with larger sam-
ple sizes that will test the feasibility of this technique on the
commonly available 3T MRI should be conducted.
Ex vivo 7T MRI is a feasible tool for perioperative evalu-
ation of SMs, and if present PC features after PN. This may
facilitate maximal sparing of renal parenchyma without
compromising oncological outcomes.
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